Karin Weyer
Impact in
- Infectious Diseases top 0.2%
- Tuberculosis Research and Epidemiology
- Epidemiology top 1%
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
Papers in
-
- Tuberculosis Research and Epidemiology 55
- HIV/AIDS drug development and treatment 4
- Epidemiology 36
- Mycobacterium research and diagnosis 22
- Pneumocystis jirovecii pneumonia detection and treatment 13
- Pneumonia and Respiratory Infections 10
- Co-authors
- Dennis Falzon (12 shared papers)Ernesto Jaramillo (11 shared papers)Mario Carlo Raviglione (11 shared papers)Kayla F. Laserson (3 shared papers)Timothy H. Holtz (3 shared papers)Katherine Floyd (6 shared papers)Christian Lienhardt (2 shared papers)Charles D. Wells (2 shared papers)
- Journals
- European Respiratory Journal (12 papers)The Journal of Infectious Diseases (8 papers)The Lancet (4 papers)Bulletin of the World Health Organization (3 papers)Journal of Clinical Microbiology (3 papers)
- Partner nations
- SwitzerlandUnited StatesSouth Africa
In The Last Decade
Karin Weyer
64 papers receiving 5.5k citations
Karin Weyer's Hit Papers
Peers
Comparison fields: 5 of 151
- Infectious Diseases 4.7k
- Epidemiology 2.6k
- Molecular Medicine 229
- Surgery 1.3k
- Applied Microbiology and Biotechnology 38
Countries citing papers authored by Karin Weyer
This map shows the geographic impact of Karin Weyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Weyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Weyer more than expected).
Fields of papers citing papers by Karin Weyer
This network shows the impact of papers produced by Karin Weyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Weyer. The network helps show where Karin Weyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin Weyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Hit paper breakdown → | 2011 | 842 |
| 2 | Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Hit paper breakdown → | 2015 | 479 |
| 3 | 2007 | 394 | |
| 4 | World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update Hit paper breakdown → | 2017 | 337 |
| 5 | 2012 | 283 | |
| 6 | Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. | 2005 | 257 |
| 7 | 2012 | 210 | |
| 8 | Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs | 2008 | 203 |
| 9 | Determinants of drug-resistant tuberculosis: analysis of 11 countries. | 2001 | 165 |
| 10 | 2012 | 155 | |
| 11 | 2015 | 136 | |
| 12 | 2016 | 133 | |
| 13 | 2016 | 115 | |
| 14 | 2018 | 115 | |
| 15 | 2014 | 110 | |
| 16 | 2014 | 108 | |
| 17 | 1997 | 102 | |
| 18 | 2008 | 99 | |
| 19 | 2011 | 94 | |
| 20 | 2012 | 88 |
About Karin Weyer
Karin Weyer is a scholar working on Infectious Diseases, Epidemiology, Surgery, Economics and Econometrics and Geriatrics and Gerontology, having authored 68 papers that have together received 5.8k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (55 papers), Mycobacterium research and diagnosis (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Pneumonia and Respiratory Infections (10 papers), Diagnosis and treatment of tuberculosis (9 papers), Infectious Diseases and Tuberculosis (9 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Impact and Responses (2 papers). The work is most often cited by research in Infectious Diseases (4.7k citations), Epidemiology (2.6k citations), Molecular Medicine (229 citations), Surgery (1.3k citations) and Applied Microbiology and Biotechnology (38 citations). Karin Weyer has collaborated with scholars based in Switzerland, United States and South Africa. Frequent co-authors include Dennis Falzon, Ernesto Jaramillo, Mario Carlo Raviglione, Kayla F. Laserson, Timothy H. Holtz, Katherine Floyd, Christian Lienhardt, Charles D. Wells, Alyssa M. Finlay and Kenneth G. Castro. Their work appears in journals such as European Respiratory Journal, The Journal of Infectious Diseases, The Lancet, Bulletin of the World Health Organization and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.